N/A
N=7
Dual-task Augmented Reality for PD DBS
Parkinson's Disease · Deep Brain Stimulation
Bottom Line
View on ClinicalTrials.gov: NCT06418152 ↗Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III: Motor Examination Score — 3.25 Score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Multi-modal treatment (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Jay Alberts
- Primary completion
- Jan 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III: Motor Examination Score |
3.25 | — |
| SECONDARY Two Minute Walk Test |
0.06 | — |
Summary
The goal of this project is to evaluate the safety and preliminary effectiveness of utilizing a digital therapeutic, Dual-task Augmented Reality Treatment (DART) protocol, for the treatment of postural instability and gait dysfunction (PIGD) in individuals with PD with a previously implanted deep brain stimulator (DBS).
Eligibility Criteria
Inclusion Criteria
- Adult with a diagnosis of idiopathic PD
- History of deep brain stimulator placement for treatment of PD
- Ability to ambulate > 10 minutes continuously without an assistive device
Exclusion Criteria
- Medical diagnosis of dementia or any neurocognitive impairment that compromises the ability to provide informed consent
->2 errors on the Short Portable Mental Status Questionnaire
- Musculoskeletal or cardiopulmonary issue that limits one's ability to engage in exercise
- Neurological disease other than Parkinson's disease that impacts motor or cognitive function
Data sourced from ClinicalTrials.gov (NCT06418152). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.